Estuary Biotherapeutics

Series-A
estuarybio.com Biotech & Healthcare San Francisco, United States 11-50
Total Funding $103M
Latest Round $103M Series-A
Last Announced Oct 16, 2026
Investors 8 Backers
Decision Makers 1 Verified

About Estuary Biotherapeutics

Estuary Biotherapeutics is a biotechnology company developing genetic medicines for serious kidney diseases.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-A
Global Headquarters San Francisco, United States
Team Size 11-50
Tracked Since Oct 17, 2026

Web & Domain Identity

Official Website estuarybio.com
Domain Registered Date Dec 26, 2022

Social & Network Presence

X / Twitter Profile @companies
LinkedIn Corporate Company Profile

Company Milestones & Timeline

2 Events
  1. Capital Raise

    Raised $103,000,000 · Series-A

    Backed by RA Capital Management, 4BIO Capital

  2. Milestone

    Website domain registered

    estuarybio.com

Investors & Backers

8
4BIO Capital
Biogen New Ventures
Deep Track Capital
GV
National Kidney Foundation
Pivotal bioVenture Partners
RA Capital Management
UPMC Enterprises

Funding History

1 Round
Series-A equity · Oct 16, 2026

Round backers: RA Capital Management, 4BIO Capital, Biogen New Ventures, Deep Track Capital, GV, National Kidney Foundation, Pivotal bioVenture Partners, UPMC Enterprises

$103,000,000 estuarybio.com

Founders & Leadership

1

Wayne Sackett

Founder

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts